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The nasopharynx is a reservoir for pathogens associated with respiratory illnesses such as
asthma. Next-generation sequencing (NGS) has been used to characterize the nasopharyn-
geal microbiome of infants and adults during health and disease; less is known, however,
about the composition and temporal dynamics (i.e., longitudinal variation) of microbiotas
from children and adolescents. Here we use NGS technology to characterize the nasopha-
ryngeal microbiomes of asthmatic children and adolescents (6 to 18 years) and determine
their stability over time.
Methods
Two nasopharyngeal washes collected 5.5 to 6.5 months apart were taken from 40 children
and adolescents with asthma living in the Washington D.C. area. Sequence data from the
16S-V4 rRNA gene region (~250 bp) were collected from the samples using the MiSeq plat-
form. Raw data were processed in mothur (SILVA123 reference database) and Operational
Taxonomic Units (OTU)-based alpha- and beta-diversity metrics were estimated. Related-
ness among samples was assessed using PCoA ordination and Procrustes analyses. Dif-
ferences in microbial diversity and taxon mean relative proportions were assessed using
linear mixed effects models. Core microbiome analyses were also performed to identify sta-
ble and consistent microbes of the nasopharynx.
Results and Discussion
A total of 2,096,584 clean 16S sequences corresponding to an average of 167 OTUs per
sample were generated. Representatives of Moraxella*, Staphylococcus*, Dolosigranulum,
Corynebacterium, Prevotella, Streptococcus*, Haemophilus*, Fusobacterium* and a Neis-
seriaceae genus accounted for 86% of the total reads. These nine genera have been previ-
ously found in the nasopharynxes of both infants and adults, but in different proportions.
OTUs from the five genera highlighted (*) above defined the nasopharyngeal core micro-
biome at the 95% level. No significant differences in alpha- and beta-diversity were
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observed between seasons, but bacterial mean relative proportions of Haemophilus, Morax-
ella, Staphylococcus and Corynebacterium varied significantly between summer-fall and
age groups (inter-patient variation). Additionally, OTUs varied significantly within patients
between time points in 35 of the 40 patients analyzed. Future cross-sectional studies should
be mindful of the temporal dynamics of the nasopharyngeal microbiota.
Introduction
The application of next-generation sequencing (NGS) technology to microbial communities
residing in the respiratory airways (i.e., airway microbiome) has shown that bacteria may play
a significant role in the onset, development, and severity of respiratory diseases such as asthma
[1–4]. Both metataxonomics and metagenomics (see [5] for distinction) have demonstrated
that airway microbiome composition and structure vary between healthy and diseased individ-
uals and revealed significant associations between representatives of several opportunistic
pathogens (Moraxella, Streptococcus, Haemophilus, Neisseria and Staphylococcus), clinical con-
ditions, and stages of asthma [3, 6–12]. Moreover, microbiome research has shown that all of
these pathogens are normal and transient residents of the nasopharynx [10]. As such, they are
mainly asymptomatic, but through the nasopharynx they can directly spread to other sections
of the respiratory tract and potentially cause asthma, otitis media or pneumonia; or invade the
bloodstream to cause sepsis and meningitis [8, 13–15].
Given the general importance of the nasopharynx as a reservoir for microbes associated
with respiratory infections [8, 16, 17], several NGS studies have investigated the microbial
composition of the nasopharynx during health and disease in both infants and adults, and in
relation to clinical factors. Most of these microbiome studies, however, have been designed in
a cross-sectional setting (i.e., one time point) [14, 18–24]. Less is known about the temporal
dynamics of the nasopharyngeal microbiota (i.e., microbial succession) within patients and,
therefore, the influence of changing environmental factors (e.g., seasonality) on the structuring
of microbial communities over time. Moreover, temporal variation complicates the prediction
of microbial profiles associated with disease progression, the assessment of intra- and inter-
patient variation, and the study of microbe-host interactions. Gut microbiome research is
increasingly showing that longitudinal (temporal) changes in bacterial community composi-
tion and function are associated with disease [25–27]. Similarly, longitudinal studies of the
nasopharyngeal microbiome in infants have revealed that certain microbial groups change
over the first two years of life in both healthy and asthmatic children [8, 15] and that micro-
biota profiles vary strongly with the seasons [8, 10]. Additionally, these studies have also
shown a high inter-patient microbial diversity, so no nasopharyngeal core microbiome could
be defined at the OTU level.
Here, we use NGS technology to explore the nasopharyngeal microbiome. We couple tar-
geted 16S rRNA sequencing (metataxonomics) with a sophisticated analytical pipeline to char-
acterize the nasal microbiome diversity of asthmatic children and adolescents (ages 6 to 18
years) and determine its stability (i.e., microbial succession) over time (5.5 to 6.5 months) and
across seasons. Our results complement previous microbiome studies of the nasopharynx
focused on younger children (<2 years of age) and adults.
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Materials and Methods
Ethics
All participants in this study were part of the AsthMaP2 (Asthma Severity Modifying Polymor-
phisms) Study. AsthMaP2 is an ongoing study of urban children and adolescents designed to
find associations among airway microbes, environmental exposures, allergic sensitivities,
genetics, and asthma. AsthMaP2 and the study presented here were approved by the Children’s
National Medical Center Institutional Review Board (Children’s National IRB), which requires
that consent is obtained and documented prior to conducting study procedures and collection
of samples for research. Written consent was obtained from all independent participants or
their legal guardians using the Children’s National IRB approved informed consent documents
(IRB No PRO00002517).
Samples and molecular analyses
Two nasal washes (W1 and W2) were collected from 40 children and adolescents (ages 6 to 18
years; mean = 11 years) enrolled in the AsthMaP2 study in two consecutive visits (5.5 to 6.5
months apart) at Children’s National Medical Center (Washington, DC) [28]. Children were
recruited from the metropolitan Washington, DC, area; they had been physician-diagnosed
with asthma for at least one year prior to recruitment and have been followed up for another
year afterwards. Individuals who reported a medical history of chronic or complex cardiore-
spiratory disease were ineligible.
Washes were procured by instilling 5 ml of isotonic sterile saline buffer into each nare,
holding it for 10 seconds and then blowing into a specimen collection container. Total DNA
was extracted using the QIAGEN QIAamp DNA Kit (Catalog # 51304). Before adding the
ATL buffer, samples were pre-incubated in 100 uL of lysozyme-TE buffer pH = 8.0 for 30 min-
utes at 37˚C. All extractions yielding >50 ng of total DNA (as indicated by NanoDrop 2000
UV-Vis Spectrophotometer measuring) were further processed. DNA extractions were pre-
pared for sequencing using the Schloss’ MiSeq_WetLab_SOP protocol (09.2015) in Kozich
et al. [29]. Each DNA sample was amplified for the V4 region (~250 bp) of the 16S rRNA gene
and libraries were sequenced in a single run of the Illumina MiSeq sequencing platform at
University of Michigan Medical School. Sequence data have been deposited in GenBank under
SRA accession number SRP069020.
Analyses
Raw FASTQ files were processed in mothur v1.35.1 [30]. Default settings were used to mini-
mize sequencing errors as described in Schloss et al. [31]. Clean sequences were aligned to the
SILVA123-based bacterial reference alignment at http://www.mothur.org. Chimeras were
removed using uchime [32] and non-chimeric sequences were classified using the naïve Bayes-
ian classifier of Wang et al. [33]. Sequences were clustered into Operational Taxonomic Units
(OTUs) at the 0.03 threshold (species level). OTU sequence representatives and taxonomy
were imported (BIOM format) into QIIME [34] for subsequent analyses. The mothur OTU
table was filtered to a minimum of 2 observations (sequences) per OTU. Samples were sub-
sampled (rarefaction analysis) to the smallest sample size (2,288 sequences) to remove the
effect of sample size bias on community composition.
Trees for phylogenetic diversity calculations were constructed using FastTree [35]. Taxo-
nomic alpha-diversity was estimated as the number of observed OTUs, but also by the Good’s
coverage, Chao1, and Shannon indices. Phylogenetic alpha-diversity was calculated by the
Faith’s phylogenetic diversity index [36]. Phylogenetic (unweighted and weighted unifrac)
Nasopharyngeal Microbiome Diversity in Pediatric Asthma
PLOS ONE | DOI:10.1371/journal.pone.0170543 January 20, 2017 3 / 13
beta-diversity metrics were calculated between pairs of samples. Dissimilarity between samples
was estimated using principal coordinates analysis (PCoA) and both unifrac distances. Pro-
crustes analysis comparing PCoA plots (weighted unifrac distances) of W1 and W2 groups
[37] was performed with 10,000 Monte Carlo iterations. Linear mixed effects models (LME)
analysis was applied to both alpha-diversity indices and taxa mean relative proportions
(response), while accounting for non-independence of intra-patient samples (random effect)
and seasons, age (years), gender, body mass index (BMI), National Asthma Education and Pre-
vention Program (NAEPP) severity level [38], and ethnic background (predictors) (S1 Table).
Phylogenetic distances were also compared between seasons using the non-parametric adonis
test from the vegan R’s library [39] while accounting for random effects and all predictors
above. Significance was determined through permutation testing after 10,000 permutations.
Finally, differences in genus mean relative proportions between visits (W1 versus W2) were
assessed for each patient using the Fisher’s exact test. The nasopharyngeal core microbiome
(OTUs that are present in a certain percentage of samples) in our 80 samples was identified at
different levels of stringency ranging from 50% to 100% of the samples. Bonferroni or Benja-
mini-Hochberg FDR multiple test correction methods were applied. All analyses were per-
formed in mothur, QIIME, STAMP [40], and RStudio [41].
Results and Discussion
The nasopharyngeal microbiome of asthmatic children
A total of 80 nasal microbiomes corresponding to 40 asthmatic children (two samples per
patient 5.5 to 6.5 months apart) were analyzed via MiSeq sequencing of 16S rRNA V4 ampli-
cons. A total of 2,096,584 sequences ranging from 2,288 to 60,806 sequences per sample
(mean = 26,207.3; median = 22,381.5) were obtained, after quality control analyses and OTU
filtering. From these data, we identified 34–394 OTUs (mean = 167) per sample belonging to
397 classified bacterial genera and 23 classified phyla (S2 and S3 Tables). About 86% of the
sequences corresponded to the following nine genera: Moraxella (35.3%), Staphylococcus
(13.9%), Dolosigranulum (9.3%), Corynebacterium (8.8%), Prevotella (6.0%), Streptococcus
(4.9%), Haemophilus (3.5%), Fusobacterium (3.0%) and Neisseriaceae genus (1.3%) (see Fig 1
and S3 Table).
Our study does not include samples from healthy children, hence we cannot assess to what
extent the microbial profiles we observe here are unique to asthmatic children. Moreover, we
are not aware of any study that has described the nasopharyngeal microbiome of healthy chil-
dren (2 to 18 years old). For comparative purposes, we have then compiled results from several
published studies describing the nasopharyngeal microbiomes of non-asthmatic infants
(defined as children between the ages of 1–18 months) and adults (Table 1). Some genera in
our study show different mean relative proportions than those seen both in infants (Coryne-
bacterium, Dolosigranulum, Flavobacterium, Haemophilus, Prevotella and Streptococcus) and
adults (Corynebacterium, Moraxella, Prevotella and Streptococcus), while others seem to show
similar mean relative proportions across all age groups (Fusobacterium, Neisseria and Staphylo-
coccus). This comparison, therefore, suggests that the nasopharyngeal microbiome profiles
observed here are different from those seen in healthy infants and adults.
The nasopharynx is considered a reservoir for commensal and potentially pathogenic
microbes inhabiting the respiratory airways and associated with acute respiratory infections,
including asthma [4, 8–10, 16, 42]. All dominant genera reported here for the nasopharynx
[several of them including pathogenic species (e.g., Moraxella, Staphylococcus and Streptococ-
cus)] have been detected in other microbiome studies of lower and upper (excluding the naso-
pharynx) respiratory airways of asthmatics [1, 16, 43, 44]. Thus, our results confirm in
Nasopharyngeal Microbiome Diversity in Pediatric Asthma
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Fig 1. Taxonomic profiles of 80 nasopharyngeal microbiomes from 40 asthmatic children. Only OTUs with a minimum total observation count of 0.1%
are shown. W1 = nasal microbiome from wash 1; W2 = nasal microbiome from wash 2 collected 5.5 to 6.5 months later. Sample pairs are alternatively
colored in red and black to facilitate their visualization.
doi:10.1371/journal.pone.0170543.g001
Table 1. Summary of studies of the nasopharyngeal microbiome in non-asthmatic patients. Number of samples (Ns), age group by month (m) and
year (yr), sequenced 16S region, patient condition and genus mean relative proportions (with SD estimates for our study) are indicated. Studies (included
ours) are ordered by patient age group.
Study Teo et al. (2015) Bogaert et al. (2011) This study Hilty et al. (2010)
Ns 487 96 80 40
Age group Infants (1–12 m) Infants (18 m) Children (6–17 yr) Adults (18 yr)
16S V4 V5–V6 V4 V3-V6
Patient condition Healthy Healthy Asthmatic Healthy
Corynebacterium 10–22 2 8.8 (13.1) 32.8
Dolosigranulum 14–26 5 9.3 (13.6) 9.9
Flavobacterium NR 10 <1 <1
Fusobacterium NR 1 3 (6.4) 2.6
Haemophilus NR 20 3.5 (12.6) 4.5
Moraxella 9–41 40 35.5 (37.0) 4.8
Neisseria NR 2 <1 <1
Prevotella NR <1 6 (14.4) 3.5
Staphylococcus 11–41 <1 13.9 (18.3) 9.1
Streptococcus NR 12 4.9 (12.8) 9.1
NR = Proportion not reported
doi:10.1371/journal.pone.0170543.t001
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children the role of the nasopharynx as a source of potential pathogens for other sections of
the respiratory tract [4, 16]. Previous studies of the nasopharyngeal microbiome in both
infants [8] and adults [16] with respiratory infections showed that their microbiomes were
comprised of the same main genera reported here for asthmatic children and adolescents (ages
of 6 to 18 years), although their mean relative proportions varied across studies. Nasopharyn-
geal microbiomes of infants (1 to 14 months) with acute respiratory infections seem to be
dominated by Haemophilus, Streptococcus, and Moraxella [8]; while nasopharyngeal micro-
biomes of adults with asthma seem to be dominated with Staphylococcus, Corynebacterium,
and Neisseria [16]. Given that in our study Moraxella and Staphylococcus are the dominant
taxa, this seems to suggest that microbial succession towards more adult-like configurations in
the nasopharynx of asthmatics does not end at early childhood (~2 years) [8, 15] and may take
longer than in other body compartments such as the gut [45].
The asthma core microbiome
The differentiation of the core microbiome of a host meta-organism or host microhabitat is a
means to differentiate the stable and consistent members and associations from the whole
community [46, 47]. The identification of core members of the meta-organism subsequently
allows for the differentiation of core pathways and metabolic functions that are provided by
the host—microbe interaction [48]. A core microbiome composed of a variable number of
OTUs was observed in the studied nasopharyngeal samples. The least stringent definition of
the core (presence in at least 50% of the samples) identified 43 OTUs, while the most stringent
definition (presence in all sampled children) included only one OTU of the genus Staphylococ-
cus. At the 95% level, the nasopharyngeal core microbiome of asthmatic children was repre-
sented by five OTUs of the genera Moraxella, Staphylococcus, Streptococcus, Haemophilus, and
Fusobacterium. These five OTUs may represent fingerprints or biological markers (pulmo-
types; [17]) of the nasopharyngeal (and potentially the airway) microbiome in asthmatic chil-
dren. Most studies of the nasopharyngeal microbiome in infants with and without respiratory
infections [8, 10, 15, 49] were not able to define a core microbiome at the OTU level due to the
high inter-individual variability of their early (and potentially more dynamic) microbiomes.
Using a less strict definition of core microbiome (i.e., OTUs present in more than 50% of all
samples and representing >0.1% of the sequences), Bogaert et al. [10] described a core micro-
biome in children 18 months of age composed of Moraxella, Haemophilus, Enhydrobacter,
Streptococcus, Dolosigranulum, and Corynebacterium. All these genera were observed in our
50% core microbiome except Enhydrobacter, and three genera (Moraxella, Haemophilus, and
Streptococcus) were observed in our 95% core microbiome. Therefore, if the consistency and
specificity (i.e., dominant in asthmatics and absent in healthy controls) of these taxa across all
“ages of asthma” are confirmed, they could potential be used to phenotype this complex and
heterogeneous disease (i.e., pulmotypes).
Temporal diversity in the nasopharyngeal microbiome
Procrustes analysis comparing PCoA plots of W1 (nasal wash 1) and W2 (nasal wash 2)
microbiomes collected 5.5 to 6.5 months apart showed a great dissimilarity between (M2 =
0.663) both datasets (Fig 2). Microbial profiles (Fig 1) and pairwise comparisons of the most
abundant genera between W1 and W2 samples (S1 Fig) also varied greatly across patients,
with some patients showing increases in bacterial mean relative proportions, some showing
the opposite trend, and others showing no visible change. Similarly, some bacterial taxa
seemed to fluctuate more than others (e.g., Moraxella versus Streptococcus) between W1 and
W2 samples (S1 Fig). Differences in OTU mean relative proportions between W1 and W2
Nasopharyngeal Microbiome Diversity in Pediatric Asthma
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microbiomes were significant in 35 (88%) of the 40 sample pairs analyzed. The number of
significant (P< 0.05) OTUs detected varied from one to 19, as indicated by the Fisher’s exact
test (effective size1% for the difference in mean relative proportions). All these results
combined indicate that members of the nasopharyngeal bacteriome of asthmatic children
change over time (5.5 to 6.5 months) on an individual basis. Our study complements previ-
ous longitudinal studies revealing differences in microbial composition between infants 2, 6
Fig 2. Procrustes analysis of 40 nasopharyngeal sample pairs collected 5.5 to 6.5 months apart. Sample pairs (red dots)
collected from the same patient are connected by a yellow bar. The length of the bar is proportional to the dissimilarity between
sample pairs.
doi:10.1371/journal.pone.0170543.g002
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Fig 3. 3D Principal Coordinates Analyses of weighted (A) and unweighted (B) unifrac distances
between 80 nasopharyngeal microbiomes colored by season.
doi:10.1371/journal.pone.0170543.g003
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and 12 months old at risk of developing respiratory infections and asthma [8]. Future
research assessing microbial succession and host-microbe interactions during asthma should
account for both intra- and inter-patient microbiome variability in the studied cohorts and
temporal dynamics at even shorter time spans than those studied here.
To further explore inter-patient diversity in our cohort, we investigated if sampling season-
ality impacted alpha- and beta-diversity and microbe (genera) mean relative proportions while
accounting for non-independence of samples, age (years), gender, BMI, NAEPP severity level,
and ethnic background (S1 Table). We did not detect significant differences (P>0.05) in alpha
diversity (observed OTUs, Good’s coverage, Chao1, Shannon and Faith–S2 Table) between
seasonal groups or any of the confounders in our linear mixed effects models (LME) analyses
(data not shown). Additionally, ordination analysis (PCoA—Fig 3) did not reveal clear dissim-
ilarities between nasopharyngeal microbiomes grouped by season for both unifac distances.
Similarly, no significant differences (P>0.05) in beta-diversity (unifrac distances) were
detected by the adonis tests between seasons while accounting for all other confounders (data
not shown). This contrasts with previous nasopharyngeal microbiome studies showing large
differences in the microbiota profiles of healthy infants during seasons [10]. No study so far
has addressed if those differences are also seen in children and adults.
At the taxon-level, our LME analyses of mean relative proportions of the most abundant
genera (Table 2) found no significant differences between seasons for all taxa but Haemophilus,
which showed a significantly (P = 0.014) higher mean relative proportion in summer (9.3%
average) compared to fall (0.3% average) (Table 2). Previous nasopharyngeal microbiome
studies have also revealed significant seasonal effects on the proportions of Haemophilus and
Moraxella in infants at risk of developing asthma [8]. Our LME analyses also showed that
patient age (6 to 18 years) is significantly associated with variation in the mean relative propor-
tions of Moraxella, Staphylococcus, and Corynebacterium. This agrees with our previous results
suggesting that the composition of the nasopharyngeal microbiome changes towards adult-
hood [8, 15].
Our study (and others) shows that nasopharyngeal microbial communities are not stable;
rather they experience structural rearrangements (deterministic or stochastic) over time.
Given the exposure of the nasopharynx, such longitudinal changes could be related to environ-
mental factors (e.g., seasonality, diet, pets), although clinical factors (e.g., age, body mass
index, neutrophil counts, medication), other microbiotas (i.e., gastrointestinal, oral), anatomi-
cal diversity (i.e., nasal microenvironments), and technical biases (e.g., DNA extraction
Table 2. Linear mixed effects (LME) models analysis. Significance (P-values) of the LME analysis of mean relative proportions of most abundant genera
(>1% of reads) and clinical and demographic variables. All four seasons were compared, but only the lowest P-values are reported.
Season Age Gender BMI Severity Classification Ethnic Background
Moraxella 0.20 0.002 0.932 0.139 0.082 0.415
Staphylococcus 0.11 0.045 0.897 0.578 0.482 0.388
Dolosigranulum 0.12 0.610 0.680 0.520 0.270 0.130
Corynebacterium 0.12 0.003 0.106 0.845 0.335 0.052
Prevotella 0.54 0.629 0.769 0.220 0.723 0.055
Streptococcus 0.16 0.065 0.456 0.762 0.691 0.387
Haemophilus 0.014 0.510 0.355 0.594 0.510 0.612
Fusobacterium 0.36 0.250 0.220 0.057 0.499 0.846
Neisseriaceae genus 0.35 0.780 0.890 0.330 0.710 0.470
Haemophilus: 0.014* (only summer-fall was significant)
doi:10.1371/journal.pone.0170543.t002
Nasopharyngeal Microbiome Diversity in Pediatric Asthma
PLOS ONE | DOI:10.1371/journal.pone.0170543 January 20, 2017 9 / 13
protocol) could also play a role [1–3, 8–10, 42, 50]. Whatever the cause, future cross-sectional
studies of the nasopharyngeal microbiome need to be mindful of the short-time dynamics of
the microbiotas occupying this human anatomical cavity.
Supporting Information
S1 Table. Clinical and demographic characteristics of the cohort of 40 patients analyzed in
this study.
(XLSX)
S2 Table. Alpha-diversity indices (Good’s coverage, observed OTUs, Chao1, Shannon and
PD) for 80 nasopharyngeal microbiomes from 40 asthmatic children.
(XLSX)
S3 Table. Absolute counts and taxonomic classification of OTUs in 80 nasopharyngeal
microbiomes from 40 asthmatic children.
(XLSX)
S1 Fig. Proportions of sequences of the most abundant bacterial genera in 80 nasopharyn-
geal microbiomes from 40 asthmatic children.
(PDF)
Acknowledgments
We thank the GWU Colonial One High Performance Computing Cluster for computational
time.
Author Contributions
Conceptualization: MP-L KAC RJF.
Data curation: MP-L LA.
Formal analysis: MP-L.
Funding acquisition: MP-L KAC RJF.
Investigation: MP-L KAC RJF.
Methodology: MP-L LA.
Project administration: MP-L KAC RJF.
Resources: MP-L KAC RJF.
Software: MP-L.
Supervision: MP-L KAC RJF.
Validation: MP-L KAC RJF.
Visualization: MP-L.
Writing – original draft: MP-L KAC RJF.
Writing – review & editing: MP-L KAC RJF.
Nasopharyngeal Microbiome Diversity in Pediatric Asthma
PLOS ONE | DOI:10.1371/journal.pone.0170543 January 20, 2017 10 / 13
References
1. Huang YJ, Boushey HA. The microbiome and asthma. Annals of the American Thoracic Society. 2014;
11 Suppl 1:S48–51.
2. Huang YJ, Boushey HA. The microbiome in asthma. The Journal of allergy and clinical immunology.
2015; 135(1):25–30. doi: 10.1016/j.jaci.2014.11.011 PMID: 25567040
3. Brar T, Nagaraj S, Mohapatra S. Microbes and asthma: the missing cellular and molecular links. Current
opinion in pulmonary medicine. 2012; 18(1):14–22. doi: 10.1097/MCP.0b013e32834dccc0 PMID:
22113000
4. Dickson RP, Huffnagle GB. The Lung Microbiome: New Principles for Respiratory Bacteriology in
Health and Disease. PLoS pathogens. 2015; 11(7):e1004923. doi: 10.1371/journal.ppat.1004923
PMID: 26158874
5. Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome. 2015; 3:31.
doi: 10.1186/s40168-015-0094-5 PMID: 26229597
6. Bisgaard H, Hermansen MN, Bonnelykke K, Stokholm J, Baty F, Skytt NL, et al. Association of bacteria
and viruses with wheezy episodes in young children: prospective birth cohort study. Bmj. 2010; 341:
c4978. doi: 10.1136/bmj.c4978 PMID: 20921080
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42. Pérez-Losada M, Crandall KA, Freishtat RJ. Comparison of two commercial DNA extraction kits for the
analysis of nasopharyngeal bacterial communities. AIMS Microbiology. 2016; 2(2):108–19.
43. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, et al. Airway microbiota and bronchial
hyperresponsiveness in patients with suboptimally controlled asthma. The Journal of allergy and clinical
immunology. 2011; 127(2):372–81 e1–3. doi: 10.1016/j.jaci.2010.10.048 PMID: 21194740
Nasopharyngeal Microbiome Diversity in Pediatric Asthma
PLOS ONE | DOI:10.1371/journal.pone.0170543 January 20, 2017 12 / 13
44. Cardenas PA, Cooper PJ, Cox MJ, Chico M, Arias C, Moffatt MF, et al. Upper airways microbiota in anti-
biotic-naive wheezing and healthy infants from the tropics of rural Ecuador. PloS one. 2012; 7(10):
e46803. doi: 10.1371/journal.pone.0046803 PMID: 23071640
45. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut
microbiome viewed across age and geography. Nature. 2012; 486(7402):222–+. doi: 10.1038/
nature11053 PMID: 22699611
46. Backhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, et al. Defining a Healthy
Human Gut Microbiome: Current Concepts, Future Directions, and Clinical Applications. Cell Host &
Microbe. 2012; 12(5):611–22.
47. Shade A, Handelsman J. Beyond the Venn diagram: the hunt for a core microbiome. Environ Microbiol.
2012; 14(1):4–12. doi: 10.1111/j.1462-2920.2011.02585.x PMID: 22004523
48. Shafquat A, Joice R, Simmons SL, Huttenhower C. Functional and phylogenetic assembly of microbial
communities in the human microbiome. Trends Microbiol. 2014; 22(5):261–6. doi: 10.1016/j.tim.2014.
01.011 PMID: 24618403
49. Biesbroek G, Wang X, Keijser BJ, Eijkemans RM, Trzcinski K, Rots NY, et al. Seven-valent pneumo-
coccal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerging infectious dis-
eases. 2014; 20(2):201–10. doi: 10.3201/eid2002.131220 PMID: 24447437
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